[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f4Atlnd1pihTUTdcyMWpxlL_JlDn_ciNQynjealmo6QE":8,"$fPaXvzBTwTbdCBRqqX2aXmwDS-PduEY3f78f1X-enLB0":55,"$fxrRIS3jwIo_K3lA2Ej7xHp1Z7BTXDjWMTajgoKHHiEI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},48524,868812,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//zdvKwwpnMtYwusNReBVaFVjt4zA4Kj7D.png","蔡文","浙江大学医学院附属第二医院","肿瘤科","住院医师",28,0,"肠癌术后肺转移常用药品安全用药指南","","https://ystcdn.venuertc.com/venue/AI/72f34d61-642f-4ade-ac4b-35370f884d45.jpg","\u003Cdiv class=\"medicine-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"mg-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肠癌术后肺转移常用药品安全用药指南\u003C/h2>\n  \n  \u003C!-- 导语部分 -->\n  \u003Cdiv class=\"mg-section mg-intro\">\n    \u003Cp>\n      日常治疗中，针对肠癌术后肺转移，医生会选择联合多种药品，包括化疗药、靶向药和口服药等。每种药品都有独特的作用机理和使用讲究。本文将详细介绍这类药品的核心用药细节，包括服用方法、常见不良反应、药物相互作用和储存方式，避免盲目搭配导致风险。一共7个重要用药要点，希望帮助大家安全高效地用药。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 01 主要药品简介及药理作用 -->\n  \u003Csection class=\"mg-section mg-bg-light mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 常用药品成分与作用机制 🧬\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\u003Cstrong>奥沙利铂（Oxaliplatin, 注射剂）\u003C/strong>：通过干扰细胞分裂期间的DNA复制，阻止肿瘤细胞增殖和修复。\u003C/li>\n      \u003Cli>\u003Cstrong>卡培他滨（Capecitabine, 片剂）\u003C/strong>：口服后代谢为5-FU，抑制癌细胞DNA合成，发挥抗肿瘤作用。\u003C/li>\n      \u003Cli>\u003Cstrong>伊立替康（Irinotecan, 注射剂）\u003C/strong>：抑制拓扑异构酶I，阻止DNA解旋和分裂。\u003C/li>\n      \u003Cli>\u003Cstrong>氟尿嘧啶（5-FU, 注射剂/口服剂型）\u003C/strong>：直接干扰DNA合成过程。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗（Bevacizumab, 注射剂）\u003C/strong>：作为靶向药，抑制血管内皮生长因子，减少肿瘤血管生成，从而抑制肿瘤生长。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">💡\u003C/span>\n      \u003Cspan>上述药物机制各有不同，化疗药主攻细胞分裂，靶向药则阻断血管新生，提升整体作用。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-note\">\n      \u003Cspan>引文：\u003C/span>Van Cutsem, E., et al. (2011). \"Efficacy and safety of bevacizumab with standard oxaliplatin- and fluoropyrimidine-based chemotherapy...\" J Clin Oncol, 29(15), 2011–2018. (APA)\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 服用时间和方法 -->\n  \u003Csection class=\"mg-section mg-bg-warm mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 正确用法与用量 ⏰\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>奥沙利铂、伊立替康与氟尿嘧啶：\u003C/strong> 均为静脉输注给药，仅限医疗机构使用，无需自行服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>卡培他滨：\u003C/strong> 多为口服片剂。\u003Cbr>\n        \u003Cspan class=\"mg-emoji\">✔️\u003C/span> 正确做法：应在早餐和晚餐后30分钟内服用，推荐用温水整片吞服。\u003Cbr>\n        \u003Cspan class=\"mg-emoji\">❗\u003C/span> 不可嚼碎、掰开或溶解服用。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong> 仅作静脉注射给药，通常与其他化疗药物配合使用，由专业医护人员操作。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>漏服处理：\u003C/strong> 如一餐漏服卡培他滨，尽快服用，若接近下次服药，则略过本次，不要补服双倍剂量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">⚠️\u003C/span>\n      \u003Cspan>自行调整药量或服用间隔易带来危险，用药时间和用量请严格遵照处方。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 剂型特点及使用小技巧 -->\n  \u003Csection class=\"mg-section mg-bg-light mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型差异及服药技巧 💊\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>卡培他滨片剂：\u003C/strong> 必须整片吞服，不可碾压或分割，防止药品吸收异常或胃肠道刺激。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>静脉注射药物：\u003C/strong> 如奥沙利铂、伊立替康、贝伐珠单抗须在医院环境下使用，不建议家庭注射，避免感染与操作风险。\n      \u003C/li>\n      \u003Cli>\n        服药时尽量用清水吞服，勿用茶、咖啡、牛奶等饮料送服，以免影响药效。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">💦\u003C/span>\n      \u003Cspan>服药时饮水充足可减少胃肠刺激，尤其是服用卡培他滨时，每次建议用不低于200ml清水。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-case\">\n      有位患者将卡培他滨嚼碎后服用，结果出现明显胃部不适。正确做法：务必整片吞服，防止不良反应。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用及避免搭配 -->\n  \u003Csection class=\"mg-section mg-bg-contrast mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用及搭配禁忌 🚦\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>卡培他滨与抗凝药（如华法林）：\u003C/strong> 并用可增强抗凝效应，增加出血风险。\u003Cbr>\n        \u003Cspan class=\"mg-emoji\">→\u003C/span> 若确需合用，应定期检测凝血功能。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗与血压药/抗血栓药：\u003C/strong> 有时增加出血或血栓风险，需密切监测。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>氟尿嘧啶与左旋门冬酰胺酶：\u003C/strong> 合用可能加重毒副反应，需医生综合评估。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>静脉化疗药与口服多种保健品：\u003C/strong> 可能影响药效，应主动告知医生正在服用的所有产品。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">💬\u003C/span>\n      \u003Cspan>用药期间，有需要加用别的药品或保健品时，务必优先征询相关医生和药师意见。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-note\">\n      引文：Saif M.W., et al. (2009). \"Interactions between capecitabine and warfarin.\" The Oncologist, 14(5), 594-602. (APA)\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 特殊人群用药注意事项 -->\n  \u003Csection class=\"mg-section mg-bg-light mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药提示 🙋‍♀️\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>老年人：\u003C/strong> 对化疗药不良反应更敏感，剂量可能需适度降低。谨防脱水、电解质紊乱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>肝肾功能异常者：\u003C/strong> 卡培他滨、伊立替康均有剂量调整建议，务必个体化处理。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>孕妇及哺乳期妇女：\u003C/strong> 本类药品普遍禁用，已知存在胎儿畸形或哺乳安全风险，必须避孕并终止哺乳。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>儿童：\u003C/strong> 上述药品大多数不推荐儿童使用，除特殊病例和个别方案外。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">🍼\u003C/span>\n      \u003Cspan>妊娠或哺乳期患者用药前，首要任务是告知医生自身状况。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-case\">\n      临床上，一位老年患者口服卡培他滨期间发现白细胞下降，及时调整剂量有效预防了严重副作用。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 06 常见不良反应及处理 -->\n  \u003Csection class=\"mg-section mg-bg-warm mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见副作用与应对措施 🩺\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>奥沙利铂：\u003C/strong> 手足麻木、感觉异常等神经系统症状多见，部分患者有过敏反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>卡培他滨：\u003C/strong> 手足综合征（出现手脚麻木、脱皮）、腹泻、食欲差。出现严重反应需停药并及时报告。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>伊立替康：\u003C/strong> 常见腹泻，有时出现迟发型，建议备好止泻药（如洛哌丁胺），但需遵医嘱。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>贝伐珠单抗：\u003C/strong> 可能导致高血压、出血、蛋白尿。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>氟尿嘧啶：\u003C/strong> 白细胞下降、口腔溃疡相对频繁。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>严重过敏反应：\u003C/strong> 包括呼吸困难、皮疹、喉头水肿，如遇以上情况，立刻就医。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">🙌\u003C/span>\n      \u003Cspan>出现不良反应应尽快联系医生，勿随意停药或自行处理重症不适。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-note\">\n      引文：Grothey A., et al. (2013). \"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.\" The Lancet, 381(9863), 303-312. (APA)\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 储存条件与用药安全提醒 -->\n  \u003Csection class=\"mg-section mg-bg-light mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存管理与安全重点 📦\u003C/h2>\n    \u003Cul class=\"mg-list\">\n      \u003Cli>\n        \u003Cstrong>卡培他滨：\u003C/strong> 应储存在干燥、阴凉处，室温（不高于25℃），避免潮湿和日晒，远离儿童。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>奥沙利铂、贝伐珠单抗：\u003C/strong> 多数为医院专用冷藏药物，不建议家庭储存或带出院外。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>开封药品：\u003C/strong> 应在有效期内用完，过期立即丢弃，勿自行调剂余药。\n      \u003C/li>\n      \u003Cli>\n        \u003Cstrong>药品混用风险：\u003C/strong> 严禁将不同种类化疗药片混装，避免混淆或交叉污染。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"mg-tip\">\n      \u003Cspan class=\"mg-emoji\">🚩\u003C/span>\n      \u003Cspan>不要自行决定停药或更换药品。药柜建议定期清理，辨认不清或模糊标签的药品应当做废弃处理。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"mg-case\">\n      一例患者将卡培他滨片误与其他药混装，导致服药混乱。正确做法：每种药物分开储存、明确标签。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 结语部分 -->\n  \u003Cdiv class=\"mg-section mg-summary\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">小结与核心提示 🌿\u003C/h2>\n    \u003Cp>\n      针对肠癌术后肺转移常用的几种化疗药和靶向药，安全用药的关键在于：\u003Cbr>\n      \u003Cspan class=\"mg-summary-bold\">一、严格遵守服药剂量和时间，遇不适及时就医处理；二、避免药物滥用或自我搭配，储存方式明确分区；三、孕妇、老年及肝肾功能异常人群更加要注意用药安全。\u003C/span>\u003Cbr>\n      用药过程中遗漏、混合、擅自更改用法都是潜在风险来源。如果有疑问，建议咨询专科医生或药师，真正实现安全、有效治疗。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003C!-- 关键英文学术文献一览 -->\n  \u003Csection class=\"mg-section mg-bg-ref mg-card\">\n    \u003Ch2 class=\"mg-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"mg-ref-list\">\n      \u003Cli>Van Cutsem, E., Cervantes, A., Nordlinger, B., & Arnold, D. (2011). Efficacy and safety of bevacizumab with standard oxaliplatin- and fluoropyrimidine-based chemotherapy in the first-line treatment of metastatic colorectal cancer: a meta-analysis and systematic review. \u003Ci>J Clin Oncol\u003C/i>, 29(15), 2011–2018.\u003C/li>\n      \u003Cli>Saif M.W., Relias V., Syrigos K. (2009). Interactions between capecitabine and warfarin. \u003Ci>The Oncologist\u003C/i>, 14(5), 594-602.\u003C/li>\n      \u003Cli>Grothey A., Van Cutsem E., Sobrero A., et al. (2013). Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. \u003Ci>The Lancet\u003C/i>, 381(9863), 303-312.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n  \n\u003C/div>\n\n\u003Cstyle>\n/* 独立全局样式，class前均加mg-前缀防冲突 */\n\n.medicine-guide-container {\n  max-width: 830px;\n  margin: 32px auto 60px auto;\n  padding: 32px 18px 22px 18px;\n  background: #fafcff;\n  box-shadow: 0 4px 24px 0 rgba(25,90,165,0.13);\n  border-radius: 18px;\n  font-family: \"PingFang SC\", \"Hiragino Sans GB\", \"Arial\", sans-serif;\n  color: #232b34;\n}\n\n.mg-title {\n  font-size: 2.2em;\n  font-weight: 600;\n  margin-bottom: 29px;\n  letter-spacing: 1px;\n  text-align: center;\n  color: #24728d;\n  background: linear-gradient(90deg,#ebf7f8 60%,#e7eafc 100%);\n  padding: 16px 0 13px 0;\n  border-radius: 13px;\n}\n\n.mg-section {\n  margin-top: 38px;\n  margin-bottom: 18px;\n  padding: 34px 10px 27px 29px;\n  border-radius: 17px;\n  box-shadow: 0 1px 12px 0 rgba(100,180,220,0.06);\n  position: relative;\n}\n\n.mg-card {\n  border: 1px solid #e0eefa;\n}\n\n.mg-bg-light {\n  background: linear-gradient(97deg, #ecf7fa 90%, #f9fcfd 100%);\n}\n\n.mg-bg-warm {\n  background: linear-gradient(80deg,#fefae3 80%,#faf7ed 100%);\n}\n\n.mg-bg-contrast {\n  background: linear-gradient(90deg, #f4f5fd 90%, #e5f7fe 100%);\n}\n\n.mg-bg-ref {\n  background: linear-gradient(91deg, #f5fafd 85%, #ebf7f8 100%);\n}\n\n.mg-intro {\n  background: linear-gradient(91deg, #f6f5ec 60%, #f9fcfd 100%);\n  border: 1px dashed #e6eccf;\n  padding: 23px 18px 16px 27px;\n  margin-bottom: 8px;\n  font-size: 1.16em;\n}\n\n.mg-subtitle {\n  font-size: 1.38em;\n  color: #24567f;\n  font-weight: 600;\n  margin-bottom: 23px;\n  text-shadow: 0 1px 0 #f8fafc;\n  letter-spacing: 0.5px;\n}\n\n.mg-list, .mg-ref-list {\n  padding-left: 21px;\n  margin-left: 0;\n  margin-bottom: 8px;\n}\n.mg-list li, .mg-ref-list li {\n  padding: 7px 0 7px 2px;\n  line-height: 1.68em;\n  font-size: 1.04em;\n}\n\n.mg-tip {\n  background: linear-gradient(93deg, #eaf7fd 60%, #fafdfe 100%);\n  border-left: 5px solid #45b7e1;\n  margin: 19px 0 10px 0;\n  padding: 11px 13px 11px 16px;\n  border-radius: 7px;\n  color: #246e98;\n  font-size: 1em;\n  letter-spacing: 0.1em;\n  display: flex;\n  align-items: center;\n}\n\n.mg-tip .mg-emoji {\n  font-size: 1.23em;\n  margin-right: 7px;\n}\n\n.mg-case {\n  background: linear-gradient(85deg, #fbeedb 90%, #f6f1ea 100%);\n  border-left: 4px solid #e4a106;\n  margin: 17px 0 5px 0;\n  padding: 11px 15px 11px 14px;\n  border-radius: 7px;\n  color: #876116;\n  font-size: 0.99em;\n  letter-spacing: 0.01em;\n}\n\n.mg-note {\n  color: #556c81;\n  background: #f5f8fc;\n  padding: 7px 16px;\n  border-radius: 6px;\n  font-size: 0.97em;\n  margin-top: 14px;\n  border-left: 4px solid #adcdec;\n}\n\n.mg-summary {\n  text-align: left;\n  background: linear-gradient(83deg, #f4fdfd 70%, #f6f9fc 100%);\n  padding: 26px 18px 19px 17px;\n  border-radius: 15px;\n  margin-top: 33px;\n  margin-bottom: 14px;\n  color: #205761;\n  font-size: 1.11em;\n}\n\n.mg-summary-bold {\n  color: #0b5f7a;\n  font-weight: 600;\n  font-size: 1.12em;\n  display: inline-block;\n  margin: 12px 0 9px 0;\n}\n\n@media screen and (max-width: 600px) {\n  .medicine-guide-container {\n    padding: 14px 4px 20px 4px;\n    border-radius: 0;\n    box-shadow: none;\n  }\n  .mg-section {\n    padding: 18px 2px 17px 5px;\n    border-radius: 7px;\n  }\n  .mg-subtitle {\n    font-size: 1.11em;\n    letter-spacing: 0;\n    margin-bottom: 12px;\n  }\n}\n\n/* 滚动时卡片层优先 */\n.mg-section {\n  z-index: 10;\n}\n\u003C/style>\n\n","\u003Cdiv class=\"medicine-guide-container\">\n  \u003Ch2 id=\"material_title\" class=\"mg-title\" style=\"color: rgb(",523,"2025-07-12 09:34:02","肠癌, 肺转移, 化疗药物, 安全用药, 贝伐珠单抗, 卡培他滨, 奥沙利铂","本指南提供肠癌术后肺转移的药物安全使用细节，包括用药时间、剂量、常见副作用及药物相互作用，助您更安全高效地管理治疗。","2025-07-17 10:24:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]